The Impact of Iris Color on the Efficacy of Low-Concentration Atropine in Controlling Myopia Progression - Top-Institutions - MDSpire

The Impact of Iris Color on the Efficacy of Low-Concentration Atropine in Controlling Myopia Progression

  • By

  • Gareth Lingham

  • James Loughman

  • Samantha SY Lee

  • Michael X. Repka

  • Eoin Kerin

  • Alicia Gómez Sánchez

  • Emmanuel Kobia-Acquah

  • Ernest Kyei Nkansah

  • Ian Flitcroft

  • David A. Mackey

  • April 27, 2026

  • 0 min

Share

Top Institutions in Optometry

Brief introduction explaining scope and methodology.

  • #1

    Singapore National Eye Centre
    Singapore National Eye Centre

    Singapore, N/A

    Key Differentiators

    • Ophthalmology
    • Myopia Research
    • Clinical Trials

  • #2

    The University of Hong Kong, Department of Ophthalmology
    The University of Hong Kong, Department of Ophthalmology

    Hong Kong, N/A

    Key Differentiators

    • Ophthalmology
    • Myopia Research
    • Clinical Pharmacology

  • #3

    University of Western Australia, School of Optometry and Vision Science
    University of Western Australia, School of Optometry and Vision Science

    Perth, Western Australia

    Key Differentiators

    • Optometry
    • Ophthalmology
    • Myopia Control

  • #4

    Queen's University Belfast, Centre for Experimental Medicine
    Queen's University Belfast, Centre for Experimental Medicine

    Belfast, Northern Ireland

    Key Differentiators

    • Ophthalmology
    • Clinical Research
    • Myopia Studies

  • #5

    Harvard Medical School, Massachusetts Eye and Ear Infirmary
    Harvard Medical School, Massachusetts Eye and Ear Infirmary

    Boston, Massachusetts

    Key Differentiators

    • Ophthalmology
    • Vision Science
    • Clinical Trials

Original Source(s)

The Impact of Iris Color on the Efficacy of Low-Concentration Atropine in Controlling Myopia Progression

  • by Gareth Lingham, James Loughman, Samantha SY Lee, Michael X. Repka, Eoin Kerin, Alicia Gómez Sánchez, Emmanuel Kobia-Acquah, Ernest Kyei Nkansah, Ian Flitcroft, David A. Mackey

  • April 27, 2026

Related Content

The Myopia Control Kit

Thomas Aller, OD, provides in-depth overviews of each myopia management option—pharmacologic therapy, soft contact lenses, orthokeratology, spectacle lenses, and environmental and behavioral interventions—so clinicians can not only provide the right option to each patient, but also address the larger economic and societal burdens of myopia.

The Rise of Intelligent Ortho-K

Research priorities for diagnostics, progression monitoring, and treatment of glaucoma in myopic eyes